Not applicableCompletedINTERVENTIONAL
GLP-1 and Microvascular Function in Type 2 Diabetes
ClinicalTrials.gov · NCT01740921 · Registry updated: 2017-02-17
- Condition / research focus
- Type 2 Diabetes
- Sponsor
- Royal Devon and Exeter NHS Foundation Trust
- Countries with listed sites
- United Kingdom
- Registry dates and results
- Start: 2011-01. Completion: 2016-02 (may be estimated). No results posted in this registry response.
Products and interventions (3)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
- Liraglutide (drug) — also listed as: Victoza, GLP-1 analogue
- diet (other) — also listed as: caloric restriction
- Aspirin (drug)
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
- Peninsula Clinical Research Facility
Exeter, United Kingdom